1. Home
  2. PHAT vs ALRS Comparison

PHAT vs ALRS Comparison

Compare PHAT & ALRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAT
  • ALRS
  • Stock Information
  • Founded
  • PHAT 2018
  • ALRS 1879
  • Country
  • PHAT United States
  • ALRS United States
  • Employees
  • PHAT N/A
  • ALRS N/A
  • Industry
  • PHAT Biotechnology: Pharmaceutical Preparations
  • ALRS Major Banks
  • Sector
  • PHAT Health Care
  • ALRS Finance
  • Exchange
  • PHAT Nasdaq
  • ALRS Nasdaq
  • Market Cap
  • PHAT 465.0M
  • ALRS 488.5M
  • IPO Year
  • PHAT 2019
  • ALRS 2019
  • Fundamental
  • Price
  • PHAT $6.96
  • ALRS $19.62
  • Analyst Decision
  • PHAT Strong Buy
  • ALRS Hold
  • Analyst Count
  • PHAT 4
  • ALRS 4
  • Target Price
  • PHAT $23.00
  • ALRS $23.25
  • AVG Volume (30 Days)
  • PHAT 971.9K
  • ALRS 103.4K
  • Earning Date
  • PHAT 03-06-2025
  • ALRS 01-31-2025
  • Dividend Yield
  • PHAT N/A
  • ALRS 4.03%
  • EPS Growth
  • PHAT N/A
  • ALRS N/A
  • EPS
  • PHAT N/A
  • ALRS 0.16
  • Revenue
  • PHAT $26,270,000.00
  • ALRS $164,503,000.00
  • Revenue This Year
  • PHAT $7,622.43
  • ALRS N/A
  • Revenue Next Year
  • PHAT $236.87
  • ALRS $26.79
  • P/E Ratio
  • PHAT N/A
  • ALRS $121.95
  • Revenue Growth
  • PHAT N/A
  • ALRS N/A
  • 52 Week Low
  • PHAT $6.07
  • ALRS $17.99
  • 52 Week High
  • PHAT $19.71
  • ALRS $25.85
  • Technical
  • Relative Strength Index (RSI)
  • PHAT 37.02
  • ALRS 45.81
  • Support Level
  • PHAT $6.36
  • ALRS $19.29
  • Resistance Level
  • PHAT $7.20
  • ALRS $19.09
  • Average True Range (ATR)
  • PHAT 0.48
  • ALRS 0.44
  • MACD
  • PHAT 0.08
  • ALRS 0.14
  • Stochastic Oscillator
  • PHAT 30.48
  • ALRS 88.11

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About ALRS Alerus Financial Corporation

Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.

Share on Social Networks: